Covered recipient · General Payments record
BRITTANY LEIGH ALIBERTI
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2021–2022
$344.76
- Reported across 13 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $241.05 | 8 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $149.88 | 3 |
| Abbott Laboratories | $24.37 | 1 |
| Xeris Pharmaceuticals, Inc. | $19.04 | 1 |
| Merck Sharp & Dohme Corporation | $16.70 | 1 |
| Lilly USA, LLC | $16.06 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $24.37 | 03/16/2022 | Food and Beverage | Undisputed | 06/30/2026 | 920108901 | CMS |
| AstraZeneca Pharmaceuticals LP | $12.99 | 01/06/2022 | Food and Beverage | Undisputed | 06/30/2026 | 915601359 | CMS |
| AstraZeneca Pharmaceuticals LP | $12.67 | 03/17/2022 | Food and Beverage | Undisputed | 06/30/2026 | 914980039 | CMS |
| AstraZeneca Pharmaceuticals LP | $124.22 | 03/31/2022 | Food and Beverage | Undisputed | 06/30/2026 | 915808265 | CMS |
| Lilly USA, LLC | $16.06 | 05/12/2022 | Food and Beverage | Undisputed | 06/30/2026 | 918454177 | CMS |
| Merck Sharp & Dohme LLC | $16.70 | 04/01/2022 | Food and Beverage | Undisputed | 06/30/2026 | 944125019 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.00 | 05/03/2022 | Food and Beverage | Undisputed | 06/30/2026 | 959743719 | CMS |
| Xeris Pharmaceuticals, Inc. | $19.04 | 06/02/2022 | Food and Beverage | Undisputed | 06/30/2026 | 946505083 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2021, 2022
- Source files
- Dataset page · Bulk file · PY2021 , PY2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.